Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan L K Van Hove

Showing results (1-10 of 98) with videos related to

Pageof 10
Sort By:
Molecular Genetics and Metabolism|October 18, 2024
The role of NMDA-receptor type glutamatergic antagonists dextromethorphan or ketamine in the treatment of nonketotic hyperglycinemia: A critical reassessmentJohan L K Van Hove
Molecular Genetics and Metabolism|October 22, 2025
Clinical utility of the ATP hydrolysis assay for the diagnosis of complex V deficiency in cultured skin fibroblastsMarisa W Friederich, Johan L K Van Hove
Molecular Genetics and Metabolism|August 16, 2011
Metabolic and monogenic causes of seizures in neonates and young infantsJohan L K Van Hove, Naomi J Lohr
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 15, 2010
Mountain States Genetics Regional Collaborative Center's Metabolic Newborn Screening Long-term Follow-up Study: a collaborative multi-site approach to newborn screening outcomes researchErica L Wright, Johan L K Van Hove, Janet Thomas, et al.
Molecular Genetics and Metabolism|November 27, 2012
Impact of geographic access to care on compliance and metabolic control in phenylketonuriaCynthia Freehauf, Johan L K Van Hove, Dexiang Gao, et al.
Pediatric Radiology|October 13, 2011
Urea cycle disorders: brain MRI and neurological outcomeWilliam R Bireley, Johan L K Van Hove, Renata C Gallagher, et al.
Journal of Inherited Metabolic Disease|November 25, 2024
The clinical utility in hospital-wide use of growth differentiation factor 15 as a biomarker for mitochondrial DNA-related disordersAndrea Cortés Fernández, Jane Estrella, Devin Oglesbee, et al.
Journal of Inherited Metabolic Disease|January 12, 2026
The History and Nosology of the Glycine Disorders: A Framework for CliniciansArthavan Selvanathan, Ashley Hertzog, Curtis R Coughlin, et al.
Journal of Inherited Metabolic Disease|October 18, 2011
Prediction of long-term outcome in glycine encephalopathy: a clinical surveyJulia B Hennermann, Jeanne-Marie Berger, Ulrike Grieben, et al.
American Journal of Medical Genetics. Part A|July 12, 2005
Clinical and molecular characterization of the first adult congenital disorder of glycosylation (CDG) type Ic patientLiangwu Sun, Erik A Eklund, Johan L K Van Hove, et al.
Pageof 10

Showing results (1-10 of 98) with videos related to

Sort By:
Pageof 10
Molecular Genetics and Metabolism|October 18, 2024
The role of NMDA-receptor type glutamatergic antagonists dextromethorphan or ketamine in the treatment of nonketotic hyperglycinemia: A critical reassessmentJohan L K Van Hove
Molecular Genetics and Metabolism|October 22, 2025
Clinical utility of the ATP hydrolysis assay for the diagnosis of complex V deficiency in cultured skin fibroblastsMarisa W Friederich, Johan L K Van Hove
Molecular Genetics and Metabolism|August 16, 2011
Metabolic and monogenic causes of seizures in neonates and young infantsJohan L K Van Hove, Naomi J Lohr
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 15, 2010
Mountain States Genetics Regional Collaborative Center's Metabolic Newborn Screening Long-term Follow-up Study: a collaborative multi-site approach to newborn screening outcomes researchErica L Wright, Johan L K Van Hove, Janet Thomas, et al.
Molecular Genetics and Metabolism|November 27, 2012
Impact of geographic access to care on compliance and metabolic control in phenylketonuriaCynthia Freehauf, Johan L K Van Hove, Dexiang Gao, et al.
Pediatric Radiology|October 13, 2011
Urea cycle disorders: brain MRI and neurological outcomeWilliam R Bireley, Johan L K Van Hove, Renata C Gallagher, et al.
Journal of Inherited Metabolic Disease|November 25, 2024
The clinical utility in hospital-wide use of growth differentiation factor 15 as a biomarker for mitochondrial DNA-related disordersAndrea Cortés Fernández, Jane Estrella, Devin Oglesbee, et al.
Journal of Inherited Metabolic Disease|January 12, 2026
The History and Nosology of the Glycine Disorders: A Framework for CliniciansArthavan Selvanathan, Ashley Hertzog, Curtis R Coughlin, et al.
Journal of Inherited Metabolic Disease|October 18, 2011
Prediction of long-term outcome in glycine encephalopathy: a clinical surveyJulia B Hennermann, Jeanne-Marie Berger, Ulrike Grieben, et al.
American Journal of Medical Genetics. Part A|July 12, 2005
Clinical and molecular characterization of the first adult congenital disorder of glycosylation (CDG) type Ic patientLiangwu Sun, Erik A Eklund, Johan L K Van Hove, et al.
Pageof 10